Delivery Order SPE2DX22D0029-SPE2D826F12VS
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,835.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $33,368.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 2, 2026, with an ultimate completion date of January 5, 2026. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $27,621.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $22,525.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 14, 2025, with completion expected by June 16, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order for pharmaceutical and medical supply products to support federal military and healthcare operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,718.36 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order, issued under a non-competitive set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $72,044.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 5, 2026, with completion expected by January 6, 2026. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $36,140.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with completion scheduled for November 12, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,312.57 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract supports...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $30,225.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,550.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement. The contractor, headquartered in Conshohocken, Pennsylvania, will...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F12VSDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $24,552.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's pharmaceutical and medical supply distribution operations, which serve military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. AmerisourceBergen, as a major pharmaceutical distributor, provides a comprehensive range of medical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The parent company, Cencora, Inc., maintains a significant indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 2031, which serves as the overarching vehicle enabling efficient fulfillment of pharmaceutical and medical commodity requirements for federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 1/7/26 |